Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
As a potent and selective oral inhibitor targeting FGFR subtypes 1/2/3, Pemigatinib provides a new treatment option for cholangiocarcinoma patients.What is the dosage of Pemigatini···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：161
Pemigatinib, brand name Damitan, is a potent and selective oral inhibitor against FGFR subtypes 1/2/3.How to use PemigatinibPemigatinibtablets should be swallowed whole, not chewed···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：146
Pemigatinibis a small molecule kinase inhibitor targeting the fibroblast growth factor receptor (FGFR), primarily for the treatment of advanced or metastatic cholangiocarcinoma cau···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：216
Pemigatinib is indicated for adult patients with advanced, metastatic, or unresectable cholangiocarcinoma with FGFR2 fusion or rearrangement confirmed by testing.What are the suita···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：210
Pemigatinib is an innovative targeted therapy that provides a new treatment option for patients with FGFR2 fusion or rearranged cholangiocarcinoma.What diseases is Pemigatinib suit···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：252
Pemigatinibis mainly used to treat specific diseases such as advanced or metastatic cholangiocarcinoma caused by FGFR2 fusion or rearrangement.What are the indications for Pemigati···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：243
Pemigatinib is used in adults to treat bile duct cancer that has spread to other parts of the body (metastatic) or cannot be removed with surgery. Pemigatinib is usually given afte···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：216
Pemigatinib is a targeted therapy drug developed by Incyte in the United States, mainly for the treatment of cholangiocarcinoma, especially in adult patients with previously treate···【more】
Article source：Captain MedicineRelease date：2024-08-12Recommended：218
Venetoclax is a drug used to treat leukemias, specifically chronic lymphocytic leukemia and acute myeloid leukemia. It effectively kills cancer cells by interfering with their surv···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：245
Venetoclax is a BCL-2 inhibitor that selectively binds to BCL-2 protein and inhibits anti-apoptotic function. This inhibition disrupts the interaction between BCL-2 and apoptosis r···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：208
Pemigatinib is a potent and selective oral antineoplastic drug targeting the FGFR subtype, primarily for the treatment of patients with advanced cholangiocarcinoma.How much is a bo···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：179
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed in many countries and regions around the world, and has achieved significant therapeutic effects and ···【more】
Article source：Captain MedicineRelease date：2024-08-09Recommended：140
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3172024-09-07
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：102025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：232025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：242025-27-11
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended：3062025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended：2692025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended：3492024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended：2492024-24-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
